Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma

Ke Lin, Ba D. Nguyen, David S Ettinger, Bennett B. Chin

Research output: Contribution to journalArticle


Purpose: This report illustrates the potential diagnostic and therapeutic utility of somatostatin receptor scintigraphy and therapy with somatostatin. Methods: In-111 pentetreotide (In-11 octreotide), a somatostatin analog, was used to define the receptor status and the extent of disease in a case of malignant thymoma. Results: Subsequent treatment with nonradioactive somatostatin inhibited tumor growth. Conclusion: In-111 octreotide may be useful to define tumor receptor status and may provide prognostic information useful in determining subsequent therapy.

Original languageEnglish (US)
Pages (from-to)24-28
Number of pages5
JournalClinical Nuclear Medicine
Issue number1
Publication statusPublished - Jan 1999



  • In-111-Octreotide Scintigraphy
  • Somatostatin Therapy
  • Thymoma

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this